Skip to main content
Clinical Trials/CTRI/2014/04/004556
CTRI/2014/04/004556
Recruiting
Phase 4

MOre REsponse on Cardiac Resynchronization Therapy (CRT) with MultiPointPacing (MPP) - More-CRT MPP

St Jude Medical India Pvt Ltd0 sites6,898 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
St Jude Medical India Pvt Ltd
Enrollment
6898
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Pms

Investigators

Sponsor
St Jude Medical India Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • Eligible patients will meet ALL the following:
  • Meets the current ESC or ACCF/AHA/HRS Class I or Class IIa indications for CRT implant (including upgrades from single or dual chamber ICDs)
  • Must be willing and able to comply with study requirements
  • Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form

Exclusion Criteria

  • Patients will be excluded if they meet ANY of the following criteria:
  • Already had a CRT device implanted
  • Myocardial Infarction, unstable angina within 40 days prior the enrollment
  • Recent cardiac revascularization (PTCA, Stent or CABG) in the 4 weeks prior to enrollment or planned for the 3 months following
  • Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) in the 3 months prior the enrollment
  • Primary valvular disease requiring surgical correction
  • Atrial Fibrillation:
  • ï?¼Persistent AF at the time of enrollment
  • ï?¼Permanent AF not treated with AV node ablation within 2 weeks from the CRT implant
  • ï?¼History or incidence of Paroxysmal or Persistent AF within 30 days prior the enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials